BERLIN, June 4, 2026 /PRNewswire/ -- Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that it developed a Research Use Only (RUO) molecular PCR test, via its subsidiary TIB MOLBIOL, for use on the ...
Add Yahoo as a preferred source to see more of our stories on Google. The Bundibugyo virus is a rare Ebola species. Credit: QINQIE99 / Shutterstock.com. Roche has announced the rapid development of a ...
Both PCR assays are designed to detect the parasite cyclospora cayetanensis and are for research use only. They run on Roche’s LightCycler 480 and LightCycler PRO systems. (Sheldon Cooper/SOPA ...
The LightCycler PRO System is designed to be the most advanced qPCR technology for both clinical diagnostics and research. The new system will advance personalised healthcare and support outbreak ...
Roche has announced the rapid development of a research-use-only (RUO) molecular polymerase chain reaction (PCR) test to detect the rare Ebola Bundibugyo virus. The development follows a surge in ...
New Roche test targeting detection of Bundibugyo virus supports efforts to address critical need during ongoing outbreaks 1 Roche's unique outbreak response capabilities enabled rapid development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results